The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis

Extracellularly released molecular inflammasome assemblies -ASC specks- cross-seed Aβ amyloid in Alzheimer’s disease. Here we show that ASC governs the extent of inflammation-induced amyloid A (AA) amyloidosis, a systemic disease caused by the aggregation and peripheral deposition of the acute-phase...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EMBO molecular medicine 2024-09, Vol.16 (9), p.2024-2042
Hauptverfasser: Losa, Marco, Emmenegger, Marc, De Rossi, Pierre, Schürch, Patrick M, Serdiuk, Tetiana, Pengo, Niccolò, Capron, Danaëlle, Bieli, Dimitri, Bargenda, Niklas, Rupp, Niels J, Carta, Manfredi C, Frontzek, Karl J, Lysenko, Veronika, Reimann, Regina R, Schwarz, Petra, Nuvolone, Mario, Westermark, Gunilla T, Nilsson, K Peter R, Polymenidou, Magdalini, Theocharides, Alexandre PA, Hornemann, Simone, Picotti, Paola, Aguzzi, Adriano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Extracellularly released molecular inflammasome assemblies -ASC specks- cross-seed Aβ amyloid in Alzheimer’s disease. Here we show that ASC governs the extent of inflammation-induced amyloid A (AA) amyloidosis, a systemic disease caused by the aggregation and peripheral deposition of the acute-phase reactant serum amyloid A (SAA) in chronic inflammatory conditions. Using super-resolution microscopy, we found that ASC colocalized tightly with SAA in human AA amyloidosis. Recombinant ASC specks accelerated SAA fibril formation and mass spectrometry after limited proteolysis showed that ASC interacts with SAA via its pyrin domain (PYD). In a murine model of inflammatory AA amyloidosis, splenic amyloid load was conspicuously decreased in Pycard −/− mice which lack ASC. Treatment with anti-ASC PYD antibodies decreased amyloid loads in wild-type mice suffering from AA amyloidosis. The prevalence of natural anti-ASC IgG (−logEC 50  ≥ 2) in 19,334 hospital patients was
ISSN:1757-4684
1757-4676
1757-4684
DOI:10.1038/s44321-024-00107-0